R Shabsigh

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Prevalence of and recent developments in female sexual dysfunction
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA rs
    Curr Psychiatry Rep 3:188-94. 2001
  2. pmc The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
    R Shabsigh
    Division of Urology, Maimonides Medical Center, Columbia University, Brooklyn, NY 11219, USA
    Int J Clin Pract 62:791-8. 2008
  3. ncbi The evolving role of testosterone in the treatment of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Int J Clin Pract 60:1087-92. 2006
  4. ncbi Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice
    A Yassin
    Clinic of Urology and Andrology, Segeberger Kliniken, Norderstedt Hamburg, Germany
    Andrologia 38:1-12. 2006
  5. ncbi Health issues of men: prevalence and correlates of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 174:662-7. 2005
  6. ncbi Testosterone therapy in erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Aging Male 7:312-8. 2004
  7. ncbi The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel
    T Ebert
    Department of Urology, Euromed Clinic, Europa Allee 1, D 90763 Fürth, Germany
    Eur Urol 47:137-46. 2005
  8. ncbi Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 172:658-63. 2004
  9. ncbi Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms
    R C Rosen
    University of Medicine and Dentistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08554 5653, USA
    Int J Impot Res 16:334-40. 2004
  10. ncbi Hypogonadism and erectile dysfunction: the role for testosterone therapy
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, New York 10032, USA
    Int J Impot Res 15:S9-13. 2003

Collaborators

Detail Information

Publications16

  1. ncbi Prevalence of and recent developments in female sexual dysfunction
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA rs
    Curr Psychiatry Rep 3:188-94. 2001
    ..Once triggered, female sexual dysfunction research went even further and raised more questions. This article addresses the prevalence of FSD and the most recent developments in this field...
  2. pmc The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
    R Shabsigh
    Division of Urology, Maimonides Medical Center, Columbia University, Brooklyn, NY 11219, USA
    Int J Clin Pract 62:791-8. 2008
    ..Methods: An Expert Panel Meeting was held in December 2006 in Vienna, Austria. In addition a comprehensive literature search was conducted...
  3. ncbi The evolving role of testosterone in the treatment of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Int J Clin Pract 60:1087-92. 2006
    ..Screening for hypogonadism may be useful in men with ED who fail prior PDE5 inhibitors, especially in populations at risk for hypogonadism such as type 2 diabetes and the metabolic syndrome...
  4. ncbi Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice
    A Yassin
    Clinic of Urology and Andrology, Segeberger Kliniken, Norderstedt Hamburg, Germany
    Andrologia 38:1-12. 2006
    ..Larger trials on the combination of alpha-adrenoceptor antagonists with PDE-5 inhibitors are necessary to develop an integrated treatment approach for BPH/LUTS patients with comorbid ED...
  5. ncbi Health issues of men: prevalence and correlates of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 174:662-7. 2005
    ..The prevalence of erectile dysfunction (ED) and its correlation with patient age, overall health and comorbidities were assessed...
  6. ncbi Testosterone therapy in erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Aging Male 7:312-8. 2004
    ..Consequently, it is important to screen for hypogonadism in men who fail PDE5 inhibitors...
  7. ncbi The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel
    T Ebert
    Department of Urology, Euromed Clinic, Europa Allee 1, D 90763 Fürth, Germany
    Eur Urol 47:137-46. 2005
    ....
  8. ncbi Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 172:658-63. 2004
    ..We compare the efficacy of testosterone gel (T-gel) versus placebo as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone...
  9. ncbi Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms
    R C Rosen
    University of Medicine and Dentistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08554 5653, USA
    Int J Impot Res 16:334-40. 2004
    ..These data suggest that QoL changes associated with ED therapy may be mediated by changes in sexual function, mood, and family relationships...
  10. ncbi Hypogonadism and erectile dysfunction: the role for testosterone therapy
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, New York 10032, USA
    Int J Impot Res 15:S9-13. 2003
    ..This opens the possibility of other combinations of testosterone and other treatments of ED. The ability to exploit multiple pathways in the physiologic processes leading to erection may help improve therapy for ED...
  11. ncbi The influence of vaginal bleeding on the sexual behavior of urban, Hispanic women and men
    A R Davis
    Department OB GYN, New York Presbyterian Hospital, New York, NY, USA
    Contraception 65:351-5. 2002
    ..001). The presence of vaginal bleeding or spotting is associated with decreases in genital sexual behaviors among urban, Hispanic women and men. Such disruptions in sexual behavior could contribute to contraceptive discontinuation...
  12. ncbi Long-term outcomes of inflatable penile implants: reliability, patient satisfaction and complication management
    A G Anastasiadis
    Department of Urology, College of Physicians and Surgeons, Columbia University, New York, USA
    Curr Opin Urol 11:619-23. 2001
    ..This review focuses on the most recent and important updates regarding product enhancements, patient satisfaction studies, and management of intra- and postoperative problems...
  13. ncbi Efficacy, safety, and use of sildenafil in urologic practice
    E Fagelman
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 57:1141-4. 2001
    ..CONCLUSIONS: Sildenafil is an effective and safe drug in the treatment of erectile dysfunction. At the first and second follow-up visit, most patients requested and received renewal...
  14. ncbi Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible
    A G Anastasiadis
    The Department of Urology, College of Physicians and Surgeons of Columbia University, New York 10032, USA
    Prostate Cancer Prostatic Dis 6:56-60. 2003
    ..Randomized studies with more patients and long follow-up periods are necessary in order to define the ideal candidate for nerve graft procedures...
  15. ncbi Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression
    L Zakaria
    Department of Urology, The College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Int Urol Nephrol 33:283-92. 2001
    ....
  16. ncbi Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans
    M Burchardt
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA
    Biol Reprod 60:398-404. 1999
    ..This study is a prelude to attempts to genetically manipulate VEGF expression in the penis as a therapy for erectile dysfunction...